Results 181 to 190 of about 260,886 (316)

Lipid Metabolism, Lipogenesis, and Resistance to Third Generation EGFR‐TKIs

Journal of Clinical Laboratory Analysis, EarlyView.
Cancer metabolism has emerged as a critical area of study in cancer research, offering insights into the complex mechanisms underlying tumor growth and development. Lipid metabolic reprogramming, especially the dynamic balance between fatty acid synthesis and fatty acid oxidation, plays significant roles in tumor progression. ABSTRACT Background Cancer
Wenhao Luo, Zun Wang, Guangzhi Ma, Wang Shen, Xiaobo Chen, Yida Liao   +5 more
wiley   +1 more source

HER2 Therapies in Non-Small Cell Lung Cancer (NSCLC). [PDF]

Int J Mol Sci
Richani Meinhardt FW, Zambrano Iglesias MI, Fernández Gómez MP, Saltaren Fonseca JF, Hussein A, Raez LE.   +5 more
europepmc   +1 more source

Optimising hypoxia PET imaging and its applications in guiding targeted radiation therapy for non‐small cell lung cancer: a scoping review

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 106-118, March 2025.
This review article reports that quantification of hypoxic volumes using PET in the pre‐radiation therapy setting is of prognostic value and indicative of treatment response in non‐small cell lung cancer. Abstract Introduction Non‐small cell lung cancer (NSCLC) is the leading cause of cancer‐related death. Definitive treatment includes chemotherapy and
Carol Marks, Michelle Leech
wiley   +1 more source

The evolution of non-surgical management in stage III non-small cell lung cancer. [PDF]

BJC Rep
Patel MS, Hammond A, Dee EC, Iyengar P.
europepmc   +1 more source

Oncogenic KRAS Rewires Stress Granule Dynamics: Mechanisms and Therapeutic Opportunities

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Stress granules (SGs) are dynamic, membrane‐less structures that form in response to various cellular stresses, including metabolic, oxidative, and therapeutic challenges. They function as adaptive hubs and reorganize protein synthesis and signaling networks to help cells survive under stress. In cancer, these condensates are often hijacked to
Msimisi Ndzinisa, Birhanetensay Masresha Altaye, Yuh‐Pyng Sher   +2 more
wiley   +1 more source

Single-cell identifies and validates human circulating Treg subtype/state Treg^fci in non-small cell lung cancer. [PDF]

Signal Transduct Target Ther
Liu X, Liu Y, Duan W, Weng J, Dai H, Liu F, Wang L, Qian M, Zhu B, Wu S, Ye Y, Yuan M, Hong S, Wang M, Cheng Y, Chen T, Wu D, Song Y, Wang X.   +18 more
europepmc   +1 more source

Biomarckers and Non Small Cell Lung Cancer: clinical pathological correlations and therapeutic perspectives. The experience of a Venetian Pneumological Network

reservedIntroduzione: Sebbene ci siano ci siano stati importanti passi avanti nella diagnosi e nel trattamento del Tumore a non piccole cellule del polmone, la neoplasia polmonare continua ad essere una delle principali cause di morte nella popolazione ...
BARP, MICHELE
core  

LINC01605 Predicts the Poor Prognosis of Non‐Small Cell Lung Cancer and Promotes Chemotherapy Resistance by Regulating miR‐7111‐5p/ELK1

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Non‐small cell lung cancer (NSCLC) is characterized by high incidence, mortality, and poor patient prognosis, with chemotherapy resistance being a common challenge. This research intends to identify key molecules involved in NSCLC and elucidate the regulatory role of the LINC01605/miR‐7111‐5p/ELK1 axis in chemotherapy resistance. LINC01605 and
Fang Zhang, Zhi‐Liang Yang, Tian‐Tian Qin, Guo‐Jun Zhang, Xiang Li   +4 more
wiley   +1 more source

Identification of ISZ-sTRAIL Protein as a Potent Anticancer Agent for EML4-ALK-Positive Non-Small-Cell Lung Cancer. [PDF]

Molecules
Hu J, Guo J, Qin T, Mao X, Liu Z, Ma L.
europepmc   +1 more source

NSCLC

Oncology Times, 2002
openaire   +2 more sources